HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sanofi Pulls Allevia 'Non-Drowsy' Claim Following MHRA Probe

Executive Summary

Sanofi's claim in a TV ad that its Allevia hay fever tablets were non drowsy contradicted the drug's summary of product characteristics, found an investigation by the UK's Medicines and Healthcare products Regulatory Agency.

You may also be interested in...



Sanofi Feeling Positive On Cialis Switch Progression As Q2 Sales Rise

As Sanofi reports Consumer Healthcare second-quarter sales up by 9%, the company is hopeful it can progress its plan to switch erectile dysfunction drug Cialis in the US following a constructive meeting with the FDA.

Sanofi Switch Gives UK Hay Fever Sufferers Additional Mass Market Option

Sanofi has switched its Allevia hay fever tablets (fexofenadine hydrochloride) in the UK, from prescription-only to general sales list status. 

Sanofi Warned Over Use Of Social Media Influencer For UK Ad Campaign

Sanofi's decision to promote its Phenergan sleep-aid through a social media influencer - even one with a relatively small following - was tantamount to a celebrity endorsement, says the UK's advertising regulator.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS152936

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel